View in EDS

A phase II trial of high-dose imatinib mesylate for relapsed or refractory c-kit positive and Bcr-Abl negative acute myeloid leukaemia: The AFR-15 trial

Saved in:
Bibliographic Details
Title: A phase II trial of high-dose imatinib mesylate for relapsed or refractory c-kit positive and Bcr-Abl negative acute myeloid leukaemia: The AFR-15 trial
Authors: Chevallier, Patrice1 patrice.chevallier@chu-nantes.fr, Hunault-Berger, Mathilde2, Larosa, Fabrice3, Dauriac, Charles4, Garand, Richard2, Harousseau, Jean-Luc1
Source: Leukemia Research. Aug2009, Vol. 33 Issue 8, p1124-1126. 3p.
Database: Academic Search Ultimate
Be the first to leave a comment!
You must be logged in first